Page last updated: 2024-10-22

amobarbital and Porphyria

amobarbital has been researched along with Porphyria in 3 studies

Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
PLUM, CM1
COWGER, ML1
LABBE, RF1
SEWELL, M1
Rees, HA1
Goldberg, A1
Cochrane, AL1
Williams, MJ1
Donald, KW1

Other Studies

3 other studies available for amobarbital and Porphyria

ArticleYear
[Porphyria following trinoal and pentymal therapy].
    Nordisk medicin, 1954, Nov-04, Volume: 52, Issue:45

    Topics: Amobarbital; Animals; Barbiturates; Porifera; Porphyrias

1954
Oxidative metabolism of tissue culture cells in the presence of porphyriainducing drugs.
    Archives of biochemistry and biophysics, 1963, Volume: 101

    Topics: Amides; Amobarbital; Carbohydrate Metabolism; Cell Respiration; Energy Metabolism; Humans; Metabolis

1963
Renal haemodialysis in porphyria.
    Lancet (London, England), 1967, Apr-29, Volume: 1, Issue:7496

    Topics: Adult; Amobarbital; Blood Chemical Analysis; Chlorpromazine; Female; Humans; Male; Mental Disorders;

1967